Burchert A, Saussele S, Michel C, Metzelder SK, Hochhaus A, Gattermann N, Crysandt M, Schafhausen P, Bormann M, Radsak MP, Guerci-Bresler A, Illmer T, Goebeler ME, Herhaus P, Teichmann LL, Franke GN, Lang F, Krause S, Moehle R, Klausmann M, Stegelmann F, Lutz C, Etienne G, Stoltefuss A, Goethert JR, Ernst T, Neubauer A, Hehlmann R, Aminossadati B, Wittenberg M, Pfirrmann M, Schade-Brittinger C, Le Coutre P, Nicolini FE (2022)
Publication Type: Conference contribution
Publication year: 2022
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Pages Range: 1501-1503
Conference Proceedings Title: BLOOD
Event location: New Orleans, LA
DOI: 10.1182/blood-2022-169324
APA:
Burchert, A., Saussele, S., Michel, C., Metzelder, S.K., Hochhaus, A., Gattermann, N.,... Nicolini, F.E. (2022). Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group. In BLOOD (pp. 1501-1503). New Orleans, LA, US: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Burchert, Andreas, et al. "Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group." Proceedings of the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA WASHINGTON: AMER SOC HEMATOLOGY, 2022. 1501-1503.
BibTeX: Download